1.Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction in Crossed Fused Ectopic Pelvic Kidney.
Kalyaperumal MURUGANANDHAM ; Avijit KUMAR ; Santosh KUMAR
Korean Journal of Urology 2014;55(11):764-767
Crossed fused renal ectopia is a rare anomaly and may be associated with pelvic ureteric junction obstruction (PUJO). The L-shaped fusion variety is even rarer. We report such a case with a crossed fused ectopic pelvic kidney (L-type) with PUJO and its successful laparoscopic management. Through this report we emphasize the importance of adequate preoperative imaging and intraoperative details to avoid mishaps.
Adolescent
;
Female
;
Humans
;
Kidney/*abnormalities
;
Kidney Diseases/*complications/congenital/surgery
;
Kidney Pelvis/*surgery
;
Laparoscopy/*methods
;
Reconstructive Surgical Procedures/*methods
;
Ureter/*surgery
;
Ureteral Obstruction/etiology/*surgery
;
Urologic Surgical Procedures/methods
2.Pharmacological studies on Buchanania lanzan Spreng.-A focus on wound healing with particular reference to anti-biofilm properties
Pattnaik Ashok ; Sarkar Ratul ; Sharma Amrita ; Yadav Kumar Kirendra ; Kumar Alekh ; Roy Paramita ; Mazumder Avijit ; Karmakar Sanmoy ; Sen Tuhinadri
Asian Pacific Journal of Tropical Biomedicine 2013;(12):967-974
Objective:To evaluate the wound healing activity of the methanolic root extract of Buchanania lanzan Spreng. (B. lanzan), with a focus on antimicrobial and anti-biofilm properties.
Methods: The extract was evaluated for its wound healing properties (excision and incision models) as evident from the analysis of tensile strength and wound contraction. The extract was also screened for antibacterial properties against different Gram positive and Gram negative bacterial strains. B. lanzan was also studied for its effect on biofilm formation and disruption of preformed biofilms. The synergistic effect of B. lanzan was determined in combination with gentamicin.
Results:Topical application of B. lanzan (10%w/w ointment) significantly increased (40.84%) the tensile strength in the incision wound model. B. lanzan also showed significant wound healing activity in excision model and such significant activity was observed from the 9th day. Whereas Soframycin displayed significant wound healing activity from the 6th day. It was found that root extracts of B. lanzan revealed significant inhibition against all tested pathogens. B. lanzan displayed antimicrobial activity against Gram positive (MIC 0.625 mg/mL) and Gram negative (MIC 0.625-1.25 mg/mL). B. lanzan was able to reduce biofilm formation and also caused disruption of preformed biofilms in a manner similar to ciprofloxacin. However, gentamicin was found to be ineffective against biofilms formed by Gram negative organism. According to the fractional inhibitory concentration index, B. lanzan displayed synergistic activity when it was combined with gentamicin.
Conclusions:From this study it may be concluded that the root extract of B. lanzan revealed significant wound healing potential, which was supported and well correlated with pronounced antibacterial activity of the tested plant parts.
3.Incidence and risk factors for postoperative nausea and vomiting in orthognathic surgery: a 10-year retrospective study
Subhabrata GHOSH ; Kirthi Kumar RAI ; Hosadurga Rudraswamy SHIVAKUMAR ; Amarnath P. UPASI ; Vinayak Gourish NAIK ; Avijit BHARAT
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2020;46(2):116-124
Objectives:
Postoperative nausea and vomiting (PONV) is considered as one of the most incessant and anguishing factors for patients who have surgery under general anesthesia. The occurrence of PONV after orthognathic surgery can lead to dehydration, infection, bleeding at the surgical site, and patient discomfort, all of which leave a patient with a negative impression of anesthesia and surgery. The purpose of this study is to assess the incidence of PONV after orthognathic surgery and to correlate it with factors related to patient, anesthesia, and surgery.
Materials and Methods:
A 10-year retrospective survey was done for patients who underwent orthognathic surgery between January 2008 and March 2018. The incidence of PONV was evaluated, correlations with factors related to patient, anesthesia, and surgery were studied, and the duration between the end of surgery and the occurrence of the first episode of PONV was tabulated.
Results:
The medical records of 109 patients were screened, out of which 101 satisfied the inclusion criteria. Amongst these patients, 60 patients (59.4%) suffered from PONV. Patient’s sex, induction agent used, intravenous fluids administered intraoperatively, duration and type of surgery, and the presence of a nasogastric tube were seen to have a significant influence on precipitating PONV. It was noted that among the patients who suffered from PONV, 61.7% of them experienced it 48-96 hours after the end of surgery.
Conclusion
Despite the improved anesthetic equipments, drugs, and surgical techniques currently used, the incidence of PONV was high in our study. Certain factors that were seen to influence PONV in this study need to be considered in order to develop an efficacious protocol to reduce PONV in orthognathic surgeries.